|Bid||62.85 x 900|
|Ask||63.26 x 2200|
|Day's Range||62.79 - 63.49|
|52 Week Range||46.90 - 68.02|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-3.33%|
|Beta (5Y Monthly)||0.89|
|Expense Ratio (net)||0.36%|
Telehealth companies enabling individuals to see physicians without stepping foot into a physical doctor’s office are having their moment, as the coronavirus pandemic confines individuals and would-be patients across the country largely to their homes.
Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.
Strong results led to solid trading in pharma ETFs over the past week.